Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Heartbeam Inc (NQ: BEAT ) 2.250 -0.040 (-1.75%) Streaming Delayed Price Updated: 3:35 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Heartbeam Inc < Previous 1 2 3 4 5 6 7 8 9 Next > BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update August 15, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety BEAT Stock Earnings: HeartBeam Misses EPS for Q2 2024 August 14, 2024 BEAT stock results show that HeartBeam missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace HeartBeam Reports Second Quarter 2024 Results August 14, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results August 01, 2024 Via Investor Brand Network BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023 March 20, 2024 BEAT stock results show that HeartBeam met analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Recap: HeartBeam Q4 Earnings March 20, 2024 Via Benzinga A Preview Of HeartBeam's Earnings March 19, 2024 Via Benzinga HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time August 01, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index July 01, 2024 Via Investor Brand Network HeartBeam Added to Russell Microcap® Index July 01, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program May 20, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias May 20, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) AIMIGo(TM) Recognized as ‘Best New ECG Technology Solution’ in Awards Program May 13, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program May 13, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report May 10, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report May 10, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety BEAT Stock Earnings: HeartBeam Misses EPS for Q1 2024 May 09, 2024 BEAT stock results show that HeartBeam missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace HeartBeam Reports First Quarter 2024 Results May 09, 2024 From HeartBeam, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session May 03, 2024 Via Benzinga BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules Conference Call to Discuss Q1 2024 Results April 25, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time April 25, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI April 09, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias April 09, 2024 From HeartBeam, Inc. Via Business Wire Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket March 22, 2024 Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion Via Benzinga BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023 March 21, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results March 20, 2024 From HeartBeam, Inc. Via Business Wire Earnings Scheduled For March 20, 2024 March 20, 2024 Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million. Via Benzinga BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System March 14, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG March 14, 2024 From HeartBeam, Inc. Via Business Wire What's Going On With Heartbeam (BEAT) Stock? March 12, 2024 Heartbeam shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The company last week said it secured two new patents. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
